Two years ago, a breakthrough study yielded exciting evidence that taurine could help combat aging. But a study published since then casts serious doubt on those earlier results. And this is actually a positive development for the science of supplementation — as the analysis below explains.
So is it time to throw taurine supplements in the garbage? Here is what the new research tells us and what it means for anyone currently taking taurine.
Table of Contents
A recap of the earlier study
Taurine is an amino acid. It is found naturally in the body, especially in the brain, heart, and muscles. It plays many roles, from energy metabolism to supporting nervous system function. And having too little can cause problems — it leads, for instance, to a condition called cardiomyopathy, which makes it hard for the heart to function properly [1].
For decades, taurine has been added to energy drinks. But more recently, interest in taurine has surged in relation to aging. A landmark study from a couple of years ago had a lot to do with this surge.
So what did that study find? There were actually two key discoveries. The first was about the impact of taurine supplementation. The researchers were interested in the potential for taurine to extend lifespan. They looked at how worms responded to extra taurine. Here is what they found: the lifespan of worms treated with taurine increased by 10 to 23% [2].
Now worms are a long way from humans. But the researchers also tested taurine's effects on mice, which are biologically much closer. And in this case, the results were equally impressive. Lifespans increased 10 to 12%, and life expectancy at 28 months went up by 18 to 25% [2].
The impact here is significant. The excitement in the research community was understandable. But even though humans are closer to mice than worms, they are still an entirely different species. Should anyone expect similar results in humans? And this is where the second key discovery in that study comes into play.
As the researchers looked at several different species, they noticed something interesting about taurine levels. It appeared those levels decreased rapidly with aging. This was true with mice and monkeys. The evidence suggested it was also true for humans [2].
Taking these two discoveries together, the researchers came to a striking conclusion. Their reasoning went like this: taurine supplements help mice and worms live longer. And taurine levels in mice and worms drop with age. So the reason taurine supplementation has this effect must be that it compensates for the natural decline in taurine levels. If that decline is prevented, the theory holds, aging slows [2].
It is a plausible hypothesis that fit the data. And it led to an obvious question: Would this same relationship hold for humans? Could circulating taurine levels be maintained through supplementation to slow aging? The authors proposed that testing this in human trials would be the next natural step [2].
The new study
A more recent study throws this convincing picture into serious doubt.
The scientists behind it noticed something important about the taurine research landscape. Though the 2023 study made headlines for uncovering a decline in taurine with aging, other studies had found the opposite to be true. As they combed through the literature, results were all over the map. Some studies found a decrease in taurine with age. Some found an increase. Some found no change [3].
The question is: What is really going on? And the answer is crucial. Because if taurine does not actually decline with age, the theory put forward in the 2023 study is wrong — and the hope that taurine supplements could help extend lifespan would be undermined.
So the researchers set out to clarify what actually happens with taurine levels as people age.
To get a definitive answer, they took a different methodological approach than the 2023 study. It had to do with how data on taurine levels in relationship to age were collected — and this turns out to be vitally important.
There are two very different ways to do this. One is a cross-sectional analysis. Researchers take a group of people of varying ages, measure their taurine levels, and look for patterns by age. That is what the authors of the earlier study did. And it appeared that levels declined with age.
But another method is a longitudinal study. Researchers take the same individuals and measure their taurine levels over time — say, 10 years apart. This approach is generally more accurate because it avoids generational or lifestyle confounders.
To illustrate why this matters, consider an example with anxiety. Cross-sectional data might suggest younger people are more anxious. But longitudinal data might reveal that today's elderly simply experienced different conditions when they were young. So it is not aging that reduces anxiety — it is generational differences.
In this new study on taurine, the researchers included both cross-sectional and longitudinal data. For humans, they used the Baltimore Longitudinal Study of Aging, with blood samples from participants taken 3 to 5 times over about 8 years. The cohort ranged in age from 26 to 100 [3].
They also included cross-sectional data from two other human cohorts, and longitudinal data for primates and mice.
A consistent pattern emerged across these different data sources. Taurine levels did not decline with age. In fact, the opposite appears to happen [3].
This overturns one of the key assertions from the 2023 study. That claim was important because it played a central role in the narrative about taurine and aging. If taurine drops naturally as people age, then maintaining levels through supplements could help combat aging. But it now appears levels do not drop.
Furthermore, the differences in taurine levels between individuals tend to be greater than the differences across a lifetime. This would make it very difficult to specify appropriate taurine levels at any particular life stage. That, in turn, means taurine levels cannot reliably serve as a measure of biological aging [3].
What is more, the researchers found taurine levels do not seem to correlate consistently with markers of aging. They examined muscle strength and body weight — standard biomarkers of aging — but found no consistent link [3].
So what does all this mean for the 2023 study? The key data point is this: taurine levels do not drop as people age. The proposed link between taurine and aging does not appear to hold. Low circulating taurine is not a driver of aging. And, therefore, supplementing with taurine probably will not slow it.
These results might seem disappointing. But they are actually a positive development for science. Studies like this one demonstrate that the process of making scientific progress is working as it is supposed to. Progress happens by proposing theories, testing them, and then continuing to refine understanding. A key part of the process is careful, rigorous testing of assumptions — and often retesting things other researchers have already looked at.
This study provides a great example. Researchers in the 2023 study concluded that taurine declines with age. But those behind this newer study had concerns about the methods used in that earlier work. They wanted to see what longitudinal data would reveal. Now the picture is clearer: that earlier conclusion was too hasty. Uncovering misunderstandings is part of moving forward, and the scientific community now understands taurine better than before.
What now?
This leaves a very practical question. If taurine does not decline with age and does not slow aging, does it still make sense to take taurine supplements?
Even after considering these new results, a nagging question remains in the research literature. Why did taurine increase the lifespans of yeast, worms, and mice in the 2023 study? The Interventions Testing Program would be well placed to take a careful look at taurine supplements to confirm or refute those earlier results. It may turn out that the benefits are real but the mechanism is not yet understood.
Other taurine benefits
Setting the aging-extension question aside, extending lifespan was never the primary reason evidence-conscious researchers and clinicians have taken interest in taurine. The more compelling rationale comes from human data, not preclinical data.
Research has uncovered some intriguing metabolic benefits. A 2024 meta-analysis looked at measures related to metabolic syndrome — a significant health concern because it increases the risks of heart disease, strokes, type 2 diabetes, and chronic inflammation [4].
Despite numerous clinical studies showing diverse health effects of taurine, inconsistencies in the literature had made it difficult to draw firm conclusions about whether taurine reduces the risk of metabolic syndrome. That is why this meta-analysis was conducted: to clarify taurine's effectiveness across the available evidence.
The authors conducted a meta-analysis of 25 randomized clinical trials involving over 1,000 participants. It found that taurine decreased fasting blood sugar levels, blood pressure, triglycerides, LDL cholesterol, HbA1c, and insulin levels [4].
Taurine had no effect on body weight. The doses used in the included studies varied between 1 and 6 g per day. The analysis also found that taurine appears safe across this dose range [4].
However, it is worth noting some important caveats with this data. Of the 25 studies, 18 lacked crucial information about how they were conducted, placing them at risk of bias. The remaining 7 had a low risk of bias. None had a high risk [4].
Another important issue is the short duration of the included studies. Most lasted no more than 2 months, with only a few extending up to a year [4].
Due to these limitations, the authors stress the need for longer-term studies to validate taurine's effects on metabolic markers.
There is also data showing taurine may help with cardiovascular health. One study of 120 individuals with high blood pressure found that taurine supplementation lowered blood pressure by over 7 units [5].
That same study found taurine improved how blood vessels respond to and regulate pressure [5].
There is also evidence that taurine supplementation improves cardiac performance in those with heart failure [6].
Further evidence is needed to strengthen these conclusions, but the direction of the human data is consistently positive.
From the MicroVitamin range
MicroVitamin+ Powder includes 1 g of taurine alongside its core 26-ingredient formula. A 2024 meta-analysis of 25 RCTs found that taurine supplementation in the 1–6 g/day range was associated with reductions in fasting blood glucose, LDL cholesterol, triglycerides, blood pressure, and HbA1c — MicroVitamin+ Powder.
Takeaway
Even if the evidence for taurine is still preliminary, there is a wide variety of experimental results all pointing in the same direction. Taurine appears to have a number of significant impacts on parameters connected to metabolic and cardiovascular health.
Any supplement decision involves weighing potential benefits against potential risks. In the case of taurine, the human evidence reviewed above suggests a favorable safety profile at doses of 1–6 g per day.
On the point of safety, there has been a new study on cancer cells that caused considerable confusion online. It identified taurine as a regulator of myeloid cancers [7].
But this was a study of existing cancer cells in a petri dish — similar to how glucose or NAD can accelerate cancer cell growth in a dish. This is very different from the effects in the human body.
So there are strong potential benefits of taurine, and from the human studies available so far, there are no known risks with supplementation at the doses studied. This picture could change in the future with better data. Based on the current body of evidence, taurine remains included in the MicroVitamin range — both MicroVitamin (which provides magnesium taurate) and MicroVitamin+ Powder (which adds a further 1 g of standalone taurine).
For now, it looks like taurine may not be the key to extending lifespan that many had hoped. But the metabolic and cardiovascular evidence continues to support a rationale for supplementation in individuals focused on those health markers.
